Press Releases

DaVita Inc. announced that the administrative law judge hearing the Company's Florida laboratory appeal has ruled that the sampling procedures and extrapolations used as the basis of the Medicare...

DaVita Inc. announced that First Coast Service Options, Inc., the Medicare carrier for the Company's Florida laboratory, has notified the Company that it will conduct a study of the utilization of...

DaVita Inc. today announced the final results of its modified Dutch auction tender offer, which expired at 9:00 a.m., New York City time, on May 30, 2002. Based on a final count by The Bank of New...

DaVita Inc. announced the preliminary results of its modified Dutch auction tender offer for up to 15 million shares of its common stock at a range of $21.00 to $25.00 per share, net to the seller...

DaVita Inc. today announced that in connection with its previously announced offer to purchase up to 20,000,000 of its common shares, it has decreased the price at which it will offer to purchase...

DaVita Inc. , today announced results for the quarter ended March 31, 2002. Continental U.S. EBITDA excluding accounts receivable recoveries was $91.9 million for the quarter. For the 12 months...

DaVita Inc. announced today that on the afternoon of May 7 it received a subpoena from the Philadelphia office of the U.S. Department of Health and Human Services, Office of the Inspector General,...

In conjunction with DaVita's first quarter earnings release, you are invited to its conference call that will be broadcast live over the Internet on May 10, 2002, at 10 am Eastern Time hosted by...

DaVita Inc. today announced that it has extended its previously announced offer to purchase up to 20,000,000 of its common shares for ten business days, until 9:00 a.m., New York City time, on...

DaVita Inc. announced that it received a letter today from First Coast Service Options, Inc., the Medicare carrier for the Company's Florida laboratory, informing the Company of a change in the...

DaVita Inc. announced that it has received notice that Amgen Inc. has increased the Wholesaler Acquisition Price for EPOGEN by 3.9%, effective April 25, 2002 at 5:01 PM Pacific Time. This pricing...

DaVita Inc. today announced that it has completed its tender offer for all of its outstanding 91/4% Senior Subordinated Notes due 2011. The note tender offer was originally announced on March 21,...

DaVita Inc. today revised the previously announced consideration to be paid in its cash tender offer for all of its outstanding 9.25% Senior Subordinated Notes due 2011. The tender offer is...

DaVita Inc. today announced that in connection with its previously announced offer to purchase up to 24,000,000 of its common shares, it has increased the price at which it will purchase the...

DaVita Inc. today announced the consideration to be paid in its cash tender offer for all of its outstanding 9.25% Senior Subordinated Notes due 2011. The tender offer is subject to the terms and...

DaVita Inc. today announced that, as of 5:00 PM, Eastern Standard Time, April 4, 2002 (the expiration date of the consent solicitation period), it had received the requisite consents from the...

DaVita Inc. is providing the following additional information, in the form of questions and answers, regarding its Tender Offer to purchase up to 24 million shares of its common stock. These...

DaVita Inc. today commenced its previously announced tender offers for up to 24,000,000 shares of its common stock and any or all of its outstanding 91/4% Senior Subordinated Notes due 2011....

DaVita Inc. announced today its plans to repurchase up to 25,000,000 shares of its common stock and any or all of its outstanding 91/4% Senior Subordinated Notes due 2011. DaVita expects to enter...

In conjunction with DaVita Inc.'s Q4 2001 Earnings, you are invited to listen to its conference call that will be broadcast live over the Internet on Wednesday, Feb. 27, 2002 at 12:30 p.m. EST....

DaVita Inc. today announced results for the period ended December 31, 2001. Continental U.S. EBITDA (earnings before interest, taxes, depreciation and amortization) for the fourth quarter was $96...

In conjunction with DaVita Inc.'s Q4 2001 Earnings, you are invited to listen to its conference call that will be broadcast live over the Internet on Wednesday, Feb. 27, 2002 at 12:30 p.m. EST....

DaVita Inc. today announced that its Board of Directors has authorized the Company to repurchase up to $200 million of the Company's common stock. The purchases are expected to be made on the open...

DaVita Inc. today announced results for the period ended September 30, 2001. Continental U.S. EBITDA (earnings before interest, taxes, depreciation and amortization) for the third quarter was...

We are planning to release our third quarter financial results on Monday November 5, 2001. A conference call to discuss the Q3 operating results is scheduled for Noon Eastern on November 5. Kent...

DaVita Inc. announced today that Elizabeth B. Kelly has joined DaVita as Vice President, Corporate Development and Mergers and Acquisitions. Ms. Kelly has joined DaVita after eight years with...

DaVita Inc. , today announced results for the period ended June 30, 2001. Net earnings for the second quarter and six months ended June 30, 2001 were $23.2 million or $0.26 per share and $44.6...

DaVita Inc. announced today that it has extended the expiration date of its offer to exchange its 9 3% Series B Senior Subordinated Notes due 2011, registered under the Securities Act, for its...

DaVita Inc. announced today its offer to exchange $225 million of its 9 1/4% Senior Subordinated Notes due 2011, which have been registered under the Securities Act of 1933, for its outstanding 9...

We are planning to release our second quarter financial results on Thursday, August 2, 2001. A conference call to discuss the Q2 operating results is scheduled for 10:30 a.m. Pacific Time on...

DaVita Inc. announced today that Nancy-Ann DeParle and William L. Roper have joined its Board of Directors. As expected, Thomas A. Scully has resigned his position on the DaVita Board of Directors...

Contact: LeAnne Zumwalt Investor Relations Total Renal Care, Inc. 310-792-2600 ext. 2072 Thursday May 10, 6:59 am Eastern Time TORRANCE, Calif., May 10 (Reuters) - DaVita Inc. (NYSE:DVA), an...

DaVita Inc. announced that it has received notice that Amgen Inc. has increased the Wholesaler Acquisition Price for EPOGEN by 3.9%, effective May 9, 2001 at 5:01 PM Pacific Time. This pricing...

DaVita Inc. , today announced results for the quarter ended March 31, 2001. Net earnings for the first quarter were $21.3 million or $0.24 per share. Continental U.S. EBITDA (earnings before...

DaVita Inc. , announced today that it has completed the sale of $225 million of its 9 1/4% Senior Subordinated Notes Due 2001 (the "Notes") in a private offering. The Notes mature on April 15,...

To: Members of the Investment Community From: LeAnne Zumwalt, Vice President Re: DaVita Inc. Q1 2001 Earnings Release Date: April 6, 2001 We are planning a conference call to discuss our Q1 2001...

DaVita Inc. , today announced results for the quarter and year ended December 31, 2000. Net earnings for the fourth quarter were $15.3 million or $0.18 per share. Continental U.S. EBITDA (earnings...

In SFW001B, DaVita, Inc. Invites You to Join Its Fourth Quarter Conference Call on the Web, moved earlier today, the "when" section of the advisory should read "11:00 EST February 27, 2001" rather...

DaVita Inc. announced today that representatives of the Civil Division of the United States Attorney's Office for the Eastern District of Pennsylvania have requested that the Company voluntarily...

DaVita, Inc. announced today that it will present at the upcoming U.S. Bancorp Piper Jaffray Healthcare Conference on Tuesday, January 30, 2001, at The Pierre Hotel in New York. The presentation...

DaVita Inc., formerly Total Renal Care Holdings, Inc. , today announced results for the quarter ended September 30, 2000. Net earnings were $13.2 million, or $0.16 per share, excluding the...

DaVita, Inc. announced today Thomas A. Scully has accepted a position on its Board of Directors. Mr. Scully, age 42, has many years of experience in healthcare regulation and legislation. From...

DaVita Inc. (f/k/a Total Renal Care Holdings, Inc.), today announced that continued improvement in revenue realization and billing and collecting operations are likely to result in 3-4% higher...

Total Renal Care Holdings, Inc. , today announced that it has completed the change in its name to DaVita Inc. and will begin trading under its new ticker symbol "DVA" on October 9, 2000. DaVita,...

In SFM164, DaVita Inc. (Total Renal Care Holdings, Inc. ) Q3 2000 Earnings, moved earlier today, we are advised by the company that the second graph should read "11:30 a.m. EDT" rather than "11:30...

We are planning a conference call to discuss our Q3 2000 results on November 9, 2000. Kent Thiry, Chairman and CEO, and Richard Whitney, CFO, will be leading the call to review our earnings...

DaVita (Total Renal Care Holdings, Inc.) , today announced results for the quarter ended June 30, 2000. Net earnings after tax were $2.3 million, or $0.03 per share, excluding previously announced...

DaVita (Total Renal Care Holdings, Inc.) (NYSE: TRL) announced today that it has signed a Stipulation of Settlement with the plaintiffs in the consolidated securities class actions that were filed...

DaVita (Total Renal Care Holdings, Inc.) (NYSE: TRL) announced today that it has completed a restructuring of its revolving and term loan credit facilities. "This constitutes another significant...

Total Renal Care Holdings, Inc. (NYSE: TRL), today announced that it will be changing its name to DaVita. "Because we are a new Company in many, many respects, our team wanted to give their...